Merck opens new research center named after Broad's Scolnick
Today Merck & Co., Inc. officially opened the Edward M. Scolnick Research Center in the heart of historic Fenway and Longwood neighborhoods. The glass-faced, 300,000-square-foot building is named after Ed Scolnick, M.D., who directs the Psychiatric Disease Initiative at Broad Institute. Scolnick is an associate member of Broad and also conducts research in its Chemical Biology Program.
Scolnick is an internationally recognized biomedical researcher and former president of Merck Research Laboratories (MRL), where he led efforts that introduced 29 new medicines and vaccines. Besides helping improve the health of patients, some of these compounds changed the ways in which certain diseases are treated.
In addition to his role at Broad, Scolnick is a professor in the Department of Biology at MIT, a research associate at McLean Hospital and senior lecturer in the Department of Genetics at Harvard. He is a native of Boston.
Massachusetts Lt. Governor Kerry Healey, Boston Mayor Thomas M. Menino and other public figures spoke at the Center's dedication ceremony. Located on the campus of Emmanuel College, the Center features 12 stories above ground and six stories below. When fully staffed, it will house about 500 employees. Scientists working in its labs will focus on finding treatments for cancer, Alzheimer's disease and obesity.
The facility is Merck's 11th major research center worldwide. "For more than a century, Merck has discovered innovative new medicines to address disease for unmet medical needs," said Raymond V. Gilmartin, chairman, president and CEO of Merck & Co., Inc. "Today we open the Edward M. Scolnick Research Center to continue that important work in the name of a prolific scientist who led Merck's research efforts for many years."